The panel outlines the stages of type 1 diabetes, focusing on the importance of early intervention to prevent complications of the disease.
Prioritizing Blood-Based CRC Tests May Lead to Higher Costs and Worse Outcomes, Study Finds
Annual colorectal cancer screening with FIT was the most cost-effective strategy among patients with low adherence, researchers reported.
Obesity & Type 2 Diabetes: An Expert Discussion
In our latest episode, 2 obesity experts discuss the importance of early intervention to reduce risk for complications, suggestions for managing patients in primary care, and more.
CRC Screening Expansion Strains Community Health Centers: Daily Dose
Your daily dose of the clinical news you may have missed.
Episode 17: Kidney Outcomes with Tirzepatide in Type 2 Diabetes
"Primary Viewpoints," a podcast from Patient Care Online, brings you an exclusive interview with Hiddo Heerspink, PhD, PharmD.
Mailed FIT Outreach Increases CRC Screening Rates: Daily Dose
FDA Approves First Generic of Liraglutide Injection to Improve Glycemic Control in Patients with Type 2 Diabetes
The FDA has approved the first generic once-daily GLP-1 injection for the improvement of glycemic control for type 2 diabetes in patients 10 years and up.